7 November 2013
Transense Technologies PLC
Exercise of Warrants
Transense Technologies plc (the "Company") announces that, on 5 November 2013, it issued 1,000,002 new ordinary shares of 1p each (the "New Ordinary Shares") following the exercise of warrants at a price of 4.5 pence per share by David Kleeman, Non-Executive Deputy Chairman of the Company.
Application will be made for these New Ordinary Shares to be admitted to trading on AIM, which is expected to occur on 14 November 2013.
Following the issue of the New Ordinary Shares, David Kleeman will have a beneficial and non-beneficial interest in 4,469,932 Ordinary Shares, representing 1.6% of the Company's total voting rights. 3,913,334 of these Ordinary Shares will be held beneficially with the balance of 556,598 Ordinary Shares being held non-beneficially.
Following the issue of the New Ordinary Shares, the Company's issued share capital will be 271,346,354 ordinary shares of 1p each, representing 271,346,354 voting rights in the Company. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
For more information, please contact:
Transense Technologies plc |
Tel: +44 (0)1869 238 380 |
Graham Storey, Chief Executive David Ford, Company Secretary |
|
N+1 Singer - Nominated Adviser and Broker Shaun Dobson, Aubrey Powell |
Tel: +44 (0)20 7496 3000 |
Newgate Threadneedle |
Tel: +44 (0) 20 7653 9850 |
Caroline Evans-Jones, Robyn McConnachie |